- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage III Melanoma in New Zealand
Total 2284 results
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Melanoma (Skin)United States
-
Columbia UniversityCompleted
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Advanced Vaginal Adenocarcinoma | Advanced Vaginal Adenosquamous Carcinoma | Advanced Vaginal Squamous Cell Carcinoma | Cervical Squamous Cell Carcinoma | Stage IB2 Cervical Cancer AJCC v6 and v7 | Stage II Cervical Cancer AJCC v7 | Stage... and other conditionsUnited States, Canada, Puerto Rico
-
Shaheer A. KhanAstraZeneca; Melanoma Research AllianceCompleted
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis; National Comprehensive Cancer NetworkCompleted
-
NYU Langone HealthTerminated
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompleted
-
Genta IncorporatedUnknown
-
Dermatologic Cooperative Oncology GroupUnknown
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Novartis PharmaceuticalsTerminatedUveal MelanomaUnited States, Australia, France, Netherlands, Spain, Norway
-
VicalCompletedMelanoma | Skin Cancer | Metastatic Melanoma | Malignant MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of British Columbia; San Diego State University; Stony Brook UniversityActive, not recruitingMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterSchering-PloughCompleted
-
Memorial Sloan Kettering Cancer CenterRockefeller UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterPfizerCompleted
-
Dr. Nina BhardwajCancer Research Institute, New York CityCompletedMelanomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Bristol-Myers SquibbCompletedMetastatic MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Metastatic Breast Carcinoma | Locally Advanced Unresectable Breast CarcinomaUnited States
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterArray BioPharmaCompleted
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
ViralyticsCompleted
-
Infinity Pharmaceuticals, Inc.TerminatedMetastatic MelanomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Cancer and Leukemia Group B; SWOG Cancer Research...CompletedMelanoma (Skin)United States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | NSCLC, Stage III | Nsclc | NSCLC Stage IIUnited States
-
NRG OncologyNational Cancer Institute (NCI)TerminatedStage III Intrahepatic Cholangiocarcinoma | Stage IVA Intrahepatic CholangiocarcinomaUnited States, Canada
-
AmpliMed CorporationCompletedMalignant MelanomaUnited States
-
Agenus Inc.SuspendedAdvanced MelanomaUnited States, Spain, United Kingdom, France, Germany, Switzerland, Belgium, Italy, Brazil, Russian Federation
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Bristol-Myers SquibbWithdrawn
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
New Mexico Cancer Care AllianceCompletedMelanomaUnited States
-
MELA Sciences, Inc.Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
ViralyticsCompletedMalignant MelanomaUnited States
-
National Cancer Institute (NCI)RecruitingClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVA Lip and Oral... and other conditionsUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
Memorial Sloan Kettering Cancer CenterIovance Biotherapeutics, Inc.Active, not recruiting
-
University of Illinois at ChicagoNational Cancer Institute (NCI)CompletedMelanoma (Skin)United States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Canadian Cancer Trials GroupActive, not recruitingStage II Breast Cancer | Stage IIIA Breast CancerUnited States, Canada, Puerto Rico